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Abstract 
Objectives: While the association between major depressive disorder (MDD) and future 
cardiovascular disease (CVD) is established, less is known about the relationship between CVD 
risk factors and future depression, and no studies have examined MDD subtypes. Our objective 
was to determine whether hypertension, tobacco use, and body mass index (BMI) differentially 
predict atypical and typical MDD in a national sample of U.S. adults. 
Methods: We examined prospective data from 22,915 adults with no depressive disorder history 
at baseline who participated in Wave 1 (2001-2002) and Wave 2 (2004-2005) of the National 
Epidemiologic Survey on Alcohol and Related Conditions (NESARC). CVD risk factors (Wave 
1) and incident MDD subtypes (Wave 2) were determined by structured interviews. 
Results: There were 252 atypical and 991 typical MDD cases. In fully-adjusted models, baseline 
hypertension (OR=0.58, 95% CI: 0.43-0.76), former tobacco use (OR=1.46, 95% CI: 1.20-1.78), 
and BMI (OR=1.32, 95% CI: 1.25-1.40; all p’s<0.001) predicted incident atypical MDD versus 
no MDD, whereas no CVD risk factor predicted incident typical MDD. Baseline hypertension 
(OR=0.52, 95% CI: 0.39-0.70), former tobacco use (OR=1.53, 95% CI: 1.22-1.93), and BMI 
(OR=1.26, 95% CI: 1.18-1.36; all p’s<0.001) also predicted incident atypical MDD versus 
typical MDD. 
Conclusions: Our study is the first to report that CVD risk factors differentially predict MDD 
subtypes, with hypertension (protective factor), former tobacco use (risk factor), and BMI (risk 
factor) being stronger predictors of incident atypical versus typical MDD. Such evidence could 
provide insights into the etiologies of MDD subtypes and inform interventions tailored to MDD 
subtype. 
Key Words: depressive disorder; atypical depression; hypertension; body mass index; tobacco 
use; prospective study 
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Introduction 
Substantial evidence supports a relationship between depressive disorders or symptoms 
and atherosclerotic cardiovascular disease (CVD). Although more than 30 years of research has 
examined depression as a predictor of new-onset CVD (1), less attention has been given to the 
plausible reverse direction – CVD risk factors as predictors of new-onset depression. Consistent 
with the latter direction is the vascular depression hypothesis, which posits that late-life 
depression (onset after age 50) results from subclinical cerebrovascular disease due, in part, to 
CVD risk factors (2,3).  
Findings of prospective studies suggest that some CVD risk factors may play a role in the 
etiology of depression. For instance, we observed that longitudinal increases in systolic blood 
pressure are associated with a future diagnosis of depression in elderly primary care patients (4); 
however, a meta-analysis of five prospective studies in the elderly detected no relationship 
between hypertension at baseline and future depression  (5). In regards to smoking, a meta-
analysis of seven prospective studies found that smokers at baseline have a 62% greater odds of 
subsequent depression than never smokers (6). With respect to obesity, a meta-analysis of 15 
prospective studies revealed that obesity at baseline is associated with a 55% greater odds of 
later depression (7). A mechanism that could explain how hypertension, smoking, and obesity 
may contribute to depression onset is systemic inflammation, as these CVD risk factors promote 
inflammation (8–10) and inflammation has been implicated in the etiology of depression (11). 
Because depression is a heterogeneous condition, it is possible that CVD risk factors may 
be stronger predictors of certain major depressive disorder (MDD) subtypes. One subtype that is 
a good candidate here is atypical MDD, which accounts for 15-40% of MDD cases (12,13). 
Among atypical MDD’s key features are the reversed somatic-vegetative symptoms of 
hyperphagia (increased appetite/weight gain) and hypersomnia (excessive sleep), while typical 
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MDD is a broader category that consists of MDD with other features (e.g., anxious or 
melancholic (12–14). Recent studies have reported that atypical MDD, compared to typical or 
melancholic MDD, is associated with increased inflammatory activation, as indicated by 
elevated circulating levels of inflammatory markers (15–19). These findings suggest that 
systemic inflammation may play a larger role in the etiology of atypical MDD versus other MDD 
subtypes, raising the possibility that CVD risk factors, which promote inflammation, may be 
stronger predictors of incident atypical MDD. To date, no studies have examined if CVD risk 
factors differentially predict the development of MDD subtypes.  
 To address this knowledge gap, we examined prospective data collected from a large 
sample of the U.S. population in the National Epidemiologic Survey on Alcohol and Related 
Conditions (NESARC). Our objective was to determine whether hypertension, tobacco use, and 
elevated body mass index (BMI) differentially predict the onset of MDD subtypes. Specifically, 
we hypothesized that these CVD risk factors would be stronger predictors of incident atypical 
MDD than of incident typical MDD. Determining whether CVD risk factors differentially 
predict depressive disorder subtypes could (a) provide new insights into the etiologies of various 
MDD subtypes and (b) inform the development of novel prevention and treatment programs 
tailored to the MDD subtype. 
Materials and Methods 
Study Design and Sample 
The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) is a 
prospective cohort study with two waves of data collection. It was conducted by the National 
Institute on Alcohol Abuse and Alcoholism with the primary purpose to determine the 
prevalence of alcohol use disorders and their associated disabilities in the noninstitutionalized 
U.S. adult civilian population. Detailed descriptions of the NESARC sampling and interview 
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methods can be found elsewhere (20–22). At Wave 1 (2001-2002), 43,093 respondents (81.0% 
response rate) completed computer-assisted home interviews assessing substance use disorders, 
psychiatric disorders, and medical conditions. Three years later (mean = 36.6 months) at Wave 2 
(2004-2005), 34,653 of the eligible Wave 1 respondents (86.7% response rate) completed a 
second home interview. Ethical approval for NESARC was provided by the U.S. Census Bureau 
and the U.S. Office of Management and Budget. 
We applied four exclusion criteria to the Wave 2 sample. First, given our objective of 
predicting new-onset depression, we excluded respondents with a lifetime history of depressive 
disorders at Wave 1 (n = 6,884). Second, because CVD onset could result in CVD risk factor 
changes due to the initiation of new cardiovascular treatments and because the prevalence of 
depression is elevated following CVD onset (23), we excluded respondents with a CVD 
diagnosis at Wave 1 (n = 2,418). Third, due to the potential effects of pregnancy on both CVD 
risk factors and MDD, we excluded respondents who were pregnant within a year of the Wave 1 
or 2 interviews (n = 1,527). Last, we excluded participants with missing data on any key 
variables (3.8%) – i.e., hypertension (n = 169), BMI (n = 651), and stressful life events (n = 89), 
leaving a final sample of 22,915 respondents. 
Measures and Procedures     
 Cardiovascular Risk Factors 
 We examined three CVD risk factors assessed at Wave 1 as predictors of incident MDD 
subtypes: hypertension, tobacco use, and BMI. Hypertension was assessed with two questions. 
Part A asked, ―In the past 12 months, have you had high blood pressure or hypertension?‖, and 
Part B asked, ―Did a doctor or other health professional tell you that you had hypertension?‖ We 
coded respondents as positive for a self-reported physician diagnosis of hypertension if they 
answered ―yes‖ to Parts A and B and coded respondents as negative if they answered ―no‖ to 
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Part A. Although repeated blood pressure measurements is the gold standard for hypertension 
diagnosis, the hypertension awareness rate in the U.S. has been found to be as high as 74% (24). 
The three-level lifetime tobacco use variable, created by NESARC personnel, consisted 
of history of cigarette, cigar, pipe, snuff, and chewing tobacco use. Respondents who reported 
using one or more tobacco products in the last year were coded as current tobacco users. Those 
who reported using at least one tobacco product more than once in the past but not in the last 
year were coded as former tobacco users, and those who reported never using tobacco products 
were coded as lifetime non-users. This NESARC variable possesses good reliability (25), and 
other investigations have observed high agreement between self-reported smoking and urinary 
cotinine levels (26,27). 
We calculated BMI (kg/m
2
) from self-reported height and weight. While measured BMI 
is more precise, evidence supports the use of self-reported BMI, as demonstrated by high 
correlations between measured and self-reported BMI, in epidemiologic studies examining 
relationships between factors (28). 
Major Depressive Disorder and Subtypes 
Lifetime MDD at baseline and incident MDD were determined by the Alcohol Use 
Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV), a fully structured 
diagnostic interview assessing mental disorders using DSM-IV criteria completed at both waves. 
This validated interview can be administered by experienced lay interviewers in clinical and 
general populations (29). We used the diagnostic variables coded by NESARC personnel that 
excluded illness-induced and substance-induced MDD and ruled out bereavement (21). Within 
the NESARC sample, the AUDIDIS-IV demonstrates good reliability and agreement with 
clinician evaluations (20,25). 
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From the Wave 2 NESARC variables, we used the NESARC coded two-level incident 
MDD outcome to create a three-level incident MDD subtype outcome. NESARC classified 
respondents, based on previous MDD history, into no incident MDD and incident MDD groups. 
To create our three-level outcome, we further classified respondents with incident MDD into 
atypical and typical MDD groups. The atypical MDD group consisted of respondents with both 
hyperphagia and hypersomnia. We coded individuals as having hyperphagia if they answered 
―yes‖ to either of the following AUDADIS-IV questions: ―During that time when your mood 
was at its lowest/you enjoyed or cared the least about things, did you gain at least 2 pounds a 
week for several weeks or at least 10 pounds altogether within a month (other than when you 
were growing or pregnant)?‖ or ―…did you find that you wanted to eat a lot more than usual for 
no special reason, most days for at least 2 weeks?‖ We coded respondents as having 
hypersomnia if they answered ―yes‖ to the AUDADIS-IV question, ―…did you sleep more than 
usual nearly every day for at least 2 weeks?‖ While other criteria for atypical MDD exist, using 
only the reversed somatic-vegetative symptoms demonstrates 78% sensitivity and 91% 
specificity and this valid approach (30) has been utilized in past studies (31–34). All other 
respondents with incident MDD were classified into the typical MDD group. 
Covariates 
The factors included as covariates in our models (all assessed at Wave 1) were selected 
because they are predictive of CVD risk factors and/or depression and, thus, are potential 
confounders of the relationships of interest (35,36). Our demographic-adjusted models included 
age, sex (0 = male, 1 = female), race/ethnicity, education level, cohabitation status, and 
unemployment status. We recoded race/ethnicity from a six-level variable to a four-level variable 
(0 = non-Hispanic White, 1 = non-Hispanic Black, 2 = Hispanic/Latino, 3 = Other) by combining 
the American Indian/Alaskan Native and Asian/Native Hawaiian categories with the Other 
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category due to low numbers of respondents in those categories. Education level was assessed by 
the question, ―Highest grade or year of school completed?‖, from which we computed a four-
level education level variable (0 = less than high school, 1 = high school or equivalent, 2 = some 
college or Associate’s degree, 3 = Bachelor’s degree or higher). Cohabitation status was assessed 
by asking, ―What is your current marital status?‖ If respondents answered with ―married‖ or 
―living with someone as if married‖, we coded them as cohabitating. We coded all others as not 
cohabitating. Unemployment status was assessed by asking, ―Which describes your present 
situation?‖ If respondents answered with ―unemployed or laid off and looking for work‖, 
―unemployed or laid off and not looking for work‖, or ―unemployed and permanently disabled‖, 
we coded them as unemployed. We coded all other as not unemployed. 
Our fully-adjusted models additionally included parental history of depression; lifetime 
anxiety, alcohol, and substance use disorders; and past-year stressful life events. If respondents 
indicated that their biological father or mother was depressed at any time, we coded them as 
positive for parental history of depression; otherwise, we coded them as negative. Respondents 
meeting criteria for panic disorder, agoraphobia, generalized anxiety disorder, or social phobia in 
the past year or prior (illness- and substance-induced disorders excluded) were coded as positive 
for lifetime anxiety disorder. Similarly, those meeting criteria for alcohol abuse or dependence 
were coded as positive for lifetime alcohol use disorder, and those meeting criteria for substance 
abuse or dependence (amphetamines, opioids, sedatives, tranquilizers, cocaine, 
inhalants/solvents, hallucinogens, cannabis, heroin, or other) were coded as positive for lifetime 
substance use disorder. Respondents not meeting criteria for each these disorders were coded as 
negative. Finally, respondents answered yes/no questions assessing whether they had 
experienced 12 stressful life events spanning health, social, job, and legal domains in the past 
year. From these data, we created a continuous past-year stressful life events variable ranging 
from 0-12 by summing the number of events reported (37). 
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Data Analysis 
 Before testing our hypothesis, we ran two logistic regression models examining the 
baseline CVD risk factors of hypertension, tobacco use, and BMI (z-scored) as simultaneous 
predictors of our two-level incident MDD outcome – no incident MDD (reference group) and 
incident MDD. Covariates in demographics-adjusted model were age, sex (male as the 
reference), race/ethnicity (3 dummy coded variables with non-Hispanic White as the reference), 
education level (3 dummy coded variables with less than high school as the reference), 
cohabitation status (not cohabitating as the reference), and unemployment status (not 
unemployed as the reference). Additional covariates in fully-adjusted model were parental 
history of depression (no parental history as the reference), lifetime anxiety disorder (no anxiety 
disorder as the reference), lifetime alcohol use disorder (no alcohol use disorder as the 
reference), lifetime substance use disorder (no substance use disorder as the reference), and past-
year stressful life events. We selected these covariates, as they are potential confounders of the 
relationships of interest (35,36). 
To test our hypothesis that CVD risk factors would be stronger predictors of incident 
atypical versus typical MDD, we ran four multinomial regression models examining the baseline 
CVD risk factors as simultaneous predictors of our three-level incident MDD subtype outcome 
(no incident MDD, incident atypical MDD, incident typical MDD). Two of these models used no 
incident MDD as the reference, and two used typical MDD as the reference. Covariates in 
demographics-adjusted and fully-adjusted models were the same as the logistic regression 
models described above. 
All analyses were conducted with SAS statistical software, version 9.3. All models were 
adjusted for oversampling, selection probability, and nonresponse using the NESARC sample 
weights. Weighted analyses provide estimates for U.S. civilian noninstitutionalized population 
based on the 2000 Decennial Census (20). 
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Results 
Baseline Cardiovascular Risk Factors and Incident Major Depression Disorder 
At Wave 1 (see Table 1), there were 4,365 (19.1%) hypertension cases, 5,524 (24.1%) 
current tobacco users, and 4,417 (19.3%) former tobacco users. The mean BMI was 27.0 kg/m
2
, 
which falls in the overweight range. At Wave 2, there were 1,243 (5.4%) incident MDD cases, of 
which 252 (20.3%) were atypical MDD and 991 (79.7%) were typical MDD. 
Baseline Cardiovascular Risk Factors Predicting Three-Year Incidence of Major 
Depression Disorder 
The demographics-adjusted logistic regression model revealed that baseline current 
tobacco use (OR = 1.13, 95% CI: 1.05-1.21, p < 0.001), former tobacco use (OR = 1.10, 95% CI: 
1.00-1.21, p = 0.047), and z-scored BMI (OR = 1.12, 95% CI: 1.08-1.17, p < 0.001) predicted 
incident MDD; however, hypertension did not (OR = 0.99, 95% CI: 0.89-1.10, p = 0.832). In the 
fully-adjusted model, z-scored BMI (OR = 1.10, 95% CI: 1.06-1.15, p < 0.001) remained a 
predictor, whereas hypertension (OR = 0.97, 95% CI: 0.87-1.07, p = 0.526), current tobacco use 
(OR = 1.03, 95% CI: 0.96-1.11, p = 0.397), and former tobacco use (OR = 1.04, 95% CI: 0.95-
1.14, p = 0.362) were not. Among the covariates in the fully-adjusted model (see Supplemental 
Table 1, Supplemental Digital Content, http://links.lww.com/PSYMED/A465), increasing age, 
non-Hispanic Black, some college or Associate’s degree, Bachelor’s degree or higher, and 
cohabitating were independently associated with a lower odds of incident MDD, whereas female, 
Hispanic/Latino, other race/ethnicity, unemployed, parental history of MDD, lifetime anxiety 
disorder, and increasing number of past-year stressful life events were independently associated 
with a greater odds of incident MDD. 
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Baseline Cardiovascular Risk Factors Predicting Three-Year Incidence of Atypical and 
Typical Major Depression Disorder 
As displayed in Table 2, the demographics-adjusted multinomial regression model using 
no incident MDD as the reference showed that baseline hypertension (42% lower odds), current 
tobacco use (25% greater odds), former tobacco use (52% greater odds), and z-scored BMI (35% 
greater odds per 1-SD increase) predicted incident atypical MDD versus no MDD. Additionally, 
baseline hypertension (12% greater odds), current tobacco use (10% greater odds), and z-scored 
BMI (6% greater odds per 1-SD increase) all predicted incident typical MDD versus no MDD. 
Former tobacco use did not predict incident typical MDD. 
The fully-adjusted model using no incident MDD as the reference yielded some similar 
and some discrepant findings (see Table 2). In line with demographics-adjusted model, 
hypertension (42% lower odds), former tobacco use (46% greater odds), and z-scored BMI (32% 
greater odds per 1-SD increase) predicted incident atypical MDD versus no MDD. In contrast to 
demographics-adjusted model, current tobacco use no longer predicted incident atypical MDD, 
and none of the CVD risk factors predicted incident typical MDD. 
Of greater relevance are the results of our models comparing atypical MDD to typical 
MDD presented in Table 3. In the demographics-adjusted model using incident typical MDD as 
the reference, baseline hypertension (48% lower odds), former tobacco use (49% greater odds), 
and z-scored BMI (27% greater odds per 1-SD increase) all predicted incident atypical MDD 
versus typical MDD. Current tobacco use did not predict incident atypical MDD. The fully-
adjusted model using incident typical MDD as the reference yielded nearly identical results (see 
Table 3). As a set, these results indicate that CVD risk factors differentially predicted the MDD 
subtypes, with hypertension (negative relationship; protective factor), former tobacco use 
(positive relationship; risk factor), and BMI (positive relationship; risk factor) being stronger 
predictors of incident atypical MDD than of incident typical MDD. 
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As is shown in Supplemental Table 1 (Supplemental Digital Content, 
http://links.lww.com/PSYMED/A465), the covariates predictive of incident typical MDD were 
nearly identical to those predictive of incident MDD, except that lifetime alcohol use disorder 
was independently associated with a greater odds of incident typical MDD. There were, 
however, notable differences for incident atypical MDD. Specifically, lifetime alcohol use 
disorder was independently associated with a lower odds, Hispanic/Latino was not associated, 
and high school or equivalent, some college or Associate's degree, and lifetime substance use 
disorder were independently associated with a greater odds of incident atypical MDD. 
Discussion 
Although past investigations have examined CVD risk factors as predictors of future 
depression, the present study is the first to test whether CVD risk factors differentially predict the 
development of MDD subtypes. In a large U.S national sample, we found partial support for our 
hypothesis that CVD risk factors would be stronger predictors of incident atypical versus typical 
MDD. Specifically, hypertension, former tobacco use, and BMI were: (a) predictors of incident 
atypical MDD but not typical MDD and (b) stronger predictors of incident atypical MDD than of 
typical MDD. While the associations of former tobacco use (46% greater odds) and BMI (32% 
greater odds per 1-SD increase) with incident atypical MDD were in the expected positive (risk 
factor) direction, the association for hypertension (42% lower odds) was in the negative 
(protective factor) direction. Current tobacco use did not predict either MDD subtype. Overall, 
the present findings suggest that certain CVD risk factors may play a greater role in the 
development of some MDD subtypes (atypical) but not others (typical). 
Our findings that former tobacco use and elevated BMI were associated with greater odds 
of future atypical depression extend and refine existing evidence linking these CVD risk factors 
to future depression in general (6,7). Although the mechanisms underlying these associations are 
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unclear, systemic inflammation is a strong candidate. Both tobacco use (carbon monoxide causes 
endothelial dysfunction and inflammatory activation; 38) and obesity (adipose tissue directly 
produces inflammatory mediators; 39) can result in elevated levels of proinflammatory cytokines 
in circulation. These cytokines can then reach the brain via several routes, including leaky 
regions in the blood-brain barrier, active cytokine transport molecules, and afferent fibers of the 
vagus nerve (11). Once in the brain, this cytokine signal can be amplified and disrupt the 
function of several other systems implicated in depression – including the hypothalamic-
pituitary-adrenal (HPA) axis and serotonergic, norepinephrinergic, and dopaminergic 
neurotransmission (11) – which could give rise to the onset of depressive symptoms and 
disorders (40). Of note, recent research indicates that atypical MDD, versus other MDD 
subtypes, is associated with elevated levels of circulating inflammatory markers (see 
Introduction). Thus, it is possible that systemic inflammation specifically promotes the onset of 
this MDD subtype. Psychosocial factors could also be operating as mechanisms underlying the 
observed associations. In particular, obesity is associated with stigma/discrimination (41) and 
body image dissatisfaction (42), both of which could increase the risk of depression. Given our 
observational study design, unknown third factors could also account for the observed 
associations; however, we did adjust our models for several factors that could operate in this 
fashion, such as socioeconomic status (education level and unemployment status) and substance 
abuse (alcohol and other substance use disorders).  
We also report two surprising results. One, our finding that hypertension was associated 
with a lower odds of incident atypical MDD conflicts with existing evidence of no association 
between this CVD risk factor and future depression in general (5). A potential explanation is that 
respondents with hypertension may have been followed more closely medically than those 
without hypertension and, thus, had a greater chance of being screened and treated for 
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depression, perhaps preventing the onset of a clinical disorder. Alternatively, the emotional-
dampening hypothesis, which posits that elevated blood pressure is associated with decreased 
affect perception (43,44), may explain why hypertension appears to be a protective factor for 
atypical MDD. Two, it was also surprising that former tobacco use, but not current use, predicted 
incident atypical MDD. Of note, current tobacco use was a significant predictor in our 
demographic adjusted model (OR = 1.25). Given that this relationship was diminished but the 
direction remained the same in our fully-adjusted model (OR = 1.14), we suspect that adjustment 
for several factors likely related to current tobacco use (e.g., anxiety disorders, substance abuse, 
and past-year stressful life events) is responsible for this attenuation. 
Although our findings are novel, there are limitations worthy of discussion. First, our 
CVD risk factor variables were based on respondent self-report. Though these self-report 
measures have been found to have acceptable validity (see Measures and Procedures), 
respondent inaccuracies may have resulted in an underestimation of true CVD risk factor-MDD 
subtype associations. Second, our tobacco use and hypertension variables were not continuous. 
Continuous measures – e.g., cumulative pack years and mean blood pressure levels – could 
provide more refined knowledge regarding the nature of the relationships. Third, only three CVD 
risk factors were measured at Wave 1 in NESARC. Examining other CVD risk factors (e.g., 
hypercholesterolemia) could provide further insights into the etiologies of MDD subtypes and, 
ultimately, inform interventions tailored to MDD subtype. Fourth, we did not have data 
pertaining to medical conditions and medications during the NESARC follow-up period, which 
could predict incident MDD. These limitations highlight the need for future prospective cohort 
studies with objective and comprehensive assessments of CVD risk factors to replicate and 
extend our findings. Our study does possess key methodological strengths, such as a large 
national sample, structured interview assessments of MDD, and the simultaneous examination of 
multiple CVD risk factors as predictors and MDD subtypes as outcomes. 
A
C
C
E
P
TE
D
Copyright © 2018 by the American Psychosomatic Society. Unauthorized reproduction of this article is prohibited.
  
 
Conclusions 
Our study is the first to report that evidence that CVD risk factors differentially predict 
the incidence of MDD subtypes, with hypertension (protective factor), former tobacco use (risk 
factor), and BMI (risk factor) being stronger predictors of incident atypical MDD than of 
incident typical MDD. From a mechanistic perspective, this knowledge raises the possibility that 
CVD risk factors – such as tobacco use and obesity – may be involved in the etiology of atypical 
MDD, possibly due to their proinflammatory effects. From a clinical perspective, such 
mechanistic insights could ultimately inform the development of novel prevention and treatment 
programs tailored to the MDD subtype. To illustrate, if our findings are replicated in future 
studies, intervention programs designed to prevent or treat atypical MDD may incorporate 
aggressive screening and management of tobacco use and obesity into their protocols and test the 
efficacy of these components for depression outcomes. 
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Table 1 
Characteristics of Respondents (N = 22,915) 
Baseline Covariates   
Age, years, mean (SD) 46.7 (17.3) 
Women, % 51.5 
Race/Ethnicity 
 
Non-Hispanic White, % 57.0 
Non-Hispanic Black, % 19.6 
Hispanic/Latino, % 18.8 
Other, % 4.5 
Education Level 
 
Less than High School, % 15.8 
High School or Equivalent, % 29.1 
Some College or Associate's Degree, % 29.7 
Bachelor's Degree or Higher, % 25.4 
Cohabitating, % 52.8 
Unemployed, % 6.0 
Parental History of Depression, % 15.3 
Lifetime Anxiety Disorder, % 5.7 
Lifetime Alcohol Use Disorder, % 26.1 
Lifetime Substance Use Disorder, % 7.6 
Number of Past-Year Stressful Life Events, mean, (SD) 1.4 (1.5) 
Baseline Cardiovascular Risk Factors   
Hypertension, % 19.1 
Tobacco Use 
 
Current, % 24.1 
Former, % 19.3 
Never, % 56.6 
Body Mass Index, kg/m
2
, mean, (SD) 27.0 (5.4) 
Depressive Disorders   
Incident Major Depressive Disorder (MDD), % 5.4 
Incident Atypical MDD, % 1.1 
Incident Typical MDD, % 4.3 
 
  A
C
C
E
P
TE
D
Copyright © 2018 by the American Psychosomatic Society. Unauthorized reproduction of this article is prohibited.
  
 
Table 2         
Results of Demographic and Fully-Adjusted Multinomial Regression Models Examining Cardiovascular Risk Factors as Predictors of 
Incident Atypical and Typical Major Depressive Disorder (MDD) with No Incident MDD as the Reference Group 
  Incident Atypical MDD Incident Typical MDD 
  Demographic-Adjusted Fully-Adjusted Demographic-Adjusted Fully-Adjusted 
  OR 
(95% CI) 
p-value 
OR 
(95% CI) 
p-value 
OR 
(95% CI) 
p-value 
OR 
(95% CI) 
p-value 
No Hypertension 1.00 --- 1.00 --- 1.00 --- 1.00 --- 
Hypertension 0.58 (0.43-0.77) <0.001 0.58 (0.43-0.76) <0.001 1.12 (1.01-1.24) 0.035 1.09 (0.98-1.21) 0.097 
            
No Tobacco Use 1.00 --- 1.00 --- 1.00 --- 1.00 --- 
Current Tobacco Use 1.25 (1.04-1.50) 0.016 1.14 (0.95-1.36) 0.165 1.10 (1.02-1.20) 0.016 1.01 (0.93-1.10) 0.835 
Former Tobacco Use 1.52 (1.25-1.86) <0.001 1.46 (1.20-1.78) <0.001 1.01 (0.91-1.12) 0.878 0.95 (0.86-1.06) 0.375 
            
Body Mass Index 1.35 (1.28-1.43) <0.001 1.32 (1.25-1.40) <0.001 1.06 (1.02-1.11) 0.010 1.05 (1.00-1.01) 0.057 
Note. Body mass index was z-scored where 1 SD = 5.4 kg/m
2
. Covariates in demographic-adjusted models model were age, sex, 
race/ethnicity, education level, cohabitation status, and unemployment status. The fully-adjusted models additionally included parental 
history of depression, lifetime anxiety disorder, lifetime alcohol use disorder, lifetime substance use disorder, and past-year stressful life 
events. 
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Table 3         
Results of Demographic and Fully-Adjusted Multinomial Regression Models Examining Cardiovascular Risk Factors as Predictors of 
Incident Atypical and No Major Depressive Disorder (MDD) with Incident Typical MDD as the Reference Group 
  Incident Atypical MDD No Incident MDD 
  Demographic-Adjusted Fully-Adjusted Demographic-Adjusted Fully-Adjusted 
  OR 
(95% CI) 
p-value 
OR 
(95% CI) 
p-value 
OR 
(95% CI) 
p-value 
OR 
(95% CI) 
p-value 
No Hypertension 1.00 --- 1.00 --- 1.00 --- 1.00 --- 
Hypertension 0.52 (0.39-0.69) <0.001 0.52 (0.39-0.70) <0.001 0.90 (0.81-0.99) 0.035 0.92 (0.83-1.02) 0.097 
 
 
  
 
  
 
  
  
No Tobacco Use 1.00 --- 1.00 --- 1.00 --- 1.00 --- 
Current Tobacco Use 1.13 (0.92-1.39) 0.238 1.13 (0.91-1.40) 0.275 0.91 (0.84-0.98) 0.016 0.99 (0.91-1.08) 0.835 
Former Tobacco Use 1.51 (1.21-1.89) <0.001 1.53 (1.22-1.93) <0.001 0.99 (0.90-1.10) 0.878 1.05 (0.95-1.16) 0.375 
 
 
  
 
  
 
  
  
Body Mass Index 1.27 (1.19-1.37) <0.001 1.26 (1.18-1.36) <0.001 0.94 (0.90-0.99) 0.010 0.96 (0.91-1.00) 0.057 
Note. Body mass index was z-scored where 1 SD = 5.4 kg/m2. Covariates in demographic-adjusted models model were age, sex, 
race/ethnicity, education level, cohabitation status, and unemployment status. The fully-adjusted models additionally included parental 
history of depression, lifetime anxiety disorder, lifetime alcohol use disorder, lifetime substance use disorder, and past-year stressful life 
events. 
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